Industry Advocacy

The Avalere analysis shows that generic drugs continue to be misplaced on higher formulary tiers, unfairly driving up costs for patients.

The new Congressional Domestic Pharmaceutical Manufacturing Caucus will work to ensure a resilient supply chain of key medicines are manufactured in the United States to strengthen national security.

NACDS’ sustained ‘Pharmacies: The Face of Neighborhood Healthcare’ campaign seeks to prevent a rollback of government policies that have enhanced patients’ access to pharmacies during the pandemic.

Pharmacists prove themselves during the pandemic, eye additional authorities.

Gaugh joined the Association for Accessible Medicines in 2012 as senior vice president of sciences and regulatory affairs.

The National Association of Chain Drug Stores is highlighting the upcoming speakers, events and sessions that are on tap at the upcoming TSE in Boston from Aug. 27 to 29.

NCPA and 207 stakeholders are urging the Senate to pass legislation to empower the FTC to bring enforcement actions against the consolidated PBM-insurer industry and its anticompetitive practices, including spread pricing and clawbacks.

Rite Aid is expediting its cage-free goal by three years.